Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Dose Escalation and Expansion of Abbv-383 in Combination with Anti-Cancer Regimens in Relapsed or Refractory Multiple Myeloma

Blood (2022) 140 (Supplement 1): 7326–7327.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals